Status:
COMPLETED
Functional and Proprioceptive Status in Patients With Hemophilic Ankle Arthropathy
Lead Sponsor:
Investigación en Hemofilia y Fisioterapia
Collaborating Sponsors:
Real Fundación Victoria Eugenia
Conditions:
Haemophilia
Eligibility:
MALE
18-45 years
Brief Summary
Introduction: Hemophilic ankle arthropathy is manifested by functional degenerative alterations (muscle strength deficit, mobility and proprioception), intra-articular and chronic pain. Design: Case-...
Eligibility Criteria
Inclusion
- Patients diagnosed with hemophilia A and B.
- Over 18 years.
- With medical diagnosis of ankle arthropathy.
- With clinical evaluation by Hemophilia Joint Health Score.
- In prophylactic treatment or on demand with FVIII / FIX concentrates for coagulation.
- No previous hemarthrosis of the ankles in the 3 months prior to evaluation.
Exclusion
- Patients with inhibitors (antibodies against FVIII or FIX).
- Patients with neurological or cognitive disorders that prevent the understanding of questionnaires and physical tests.
- Failure to sign the informed consent document
Key Trial Info
Start Date :
June 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 23 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05425888
Start Date
June 22 2022
End Date
December 23 2022
Last Update
February 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad Católica San Antonio
Murcia, Spain